Department of Pediatrics with Clinical Assessment Unit.
Clinic of Oncology, Child Hematology, Clinical Transplantology and Pediatry, Medical University of Warsaw.
J Pediatr Hematol Oncol. 2022 Mar 1;44(2):e537-e538. doi: 10.1097/MPH.0000000000002166.
Patients with hemato-oncologic diseases are particularly vulnerable to severe infections. Adult patients with blood cancers infected with SARS-CoV-2 had poorer treatment outcomes and higher mortality than patients with COVID-19 without burden. However, in pediatric patients with hemato-oncologic diseases the course of COVID-19 is milder than in adults in the same group of patients. In this report, we describe the case of our patient with acute lymphoblastic leukemia infected with SARS-CoV-2 and treated with remdesivir. We also review the existing literature of pediatric patients who have been diagnosed with both hemato-oncologic diseases and COVID-19.
血液肿瘤疾病患者特别容易受到严重感染。感染 SARS-CoV-2 的血液癌症成年患者的治疗结果比无负担的 COVID-19 患者差，死亡率更高。然而，在患有血液肿瘤疾病的儿科患者中，COVID-19 的病程比同组成年患者轻。在本报告中，我们描述了一例感染 SARS-CoV-2 并接受瑞德西韦治疗的急性淋巴细胞白血病患者。我们还回顾了已诊断出患有血液肿瘤疾病和 COVID-19 的儿科患者的现有文献。
